MedPath

Resistant Starch, Antioxidant Status and Insulin Resistance

Not Applicable
Completed
Conditions
Obesity
Overweight
Interventions
Dietary Supplement: Hi-maize resistant starch
Dietary Supplement: Maltodextrin
Registration Number
NCT01992783
Lead Sponsor
Urmia University of Medical Sciences
Brief Summary

The aim of this study is to evaluate whether supplementation with resistant starch improves biomarkers associated with antioxidant status and insulin resistance in subjects with overweight and obesity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Overweight and obese adults
  • Age: 20-50 years
Exclusion Criteria
  • weight loss or gain (more than10%) over the past 6 months, or weight loss (more than 5%) over the past 1 month
  • pregnancy, lactation or menopause
  • History of acute disease or clinical evidence of cancer, acute or chronic inflammatory diseases, cardiovascular disease, renal disease, liver disease, thyroid or endocrine disease
  • Gastrointestinal disease of which ingredients found in the study products have adverse effects on that
  • Use of antihypertensive, lipid lowering or glucose lowering medications
  • Taking antioxidant, vitamin, and/or mineral supplements
  • smoking

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Hi-maize resistant starchHi-maize resistant starch13.5 g/day
MaltodextrinMaltodextrin13.5 g/day
Primary Outcome Measures
NameTimeMethod
Antioxidant status4 weeks

Superoxide dismutase (SOD), Plasma malondialdehyde (MDA), Total antioxidant capacity (TAC)

Secondary Outcome Measures
NameTimeMethod
Anthropometric parameters4 weeks

Height, Weight, Body Mass Index (BMI), Waist circumference

Lipid profile4 weeks

Triglyceride, Total cholesterol, HDL-cholesterol, LDL-cholesterol, Total cholesterol/HDL-cholesterol

Blood pressure4 weeks
Insulin resistance4 weeks

Fasting glucose, Fasting insulin, Insulin resistant (HOMA-IR)

© Copyright 2025. All Rights Reserved by MedPath